exp3174 has been researched along with allisartan isoproxil in 2 studies
| Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (allisartan isoproxil) | Trials (allisartan isoproxil) | Recent Studies (post-2010) (allisartan isoproxil) |
|---|---|---|---|---|---|
| 236 | 29 | 43 | 11 | 3 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Fang, L; Hao, R; Huang, H; Lin, S; Shao, Y; Sun, J; Tong, X; Wang, A; Wang, Y; Wu, Y; Yi, W; Yu, J; Zhao, H; Zhu, J | 1 |
| Bai, J; Cai, L; Miao, Z; Si, Y; Sun, J; Wei, Y; Xiao, Y; Xing, W; Ye, H | 1 |
2 other study(ies) available for exp3174 and allisartan isoproxil
| Article | Year |
|---|---|
Pharmacokinetics and Drug-Drug Interaction of Allisartan Isoproxil and Indapamide Sustained-Release Formulation.
Topics: Delayed-Action Preparations; Drug Interactions; Humans; Hypotension; Indapamide | 2023 |
Allisartan Isoproxil Promotes Uric Acid Excretion by Interacting with Intestinal Urate Transporters in Hyperuricemic Zebrafish (Danio rerio).
Topics: Animals; Hyperuricemia; Kidney; Losartan; Uric Acid; Zebrafish | 2023 |